tiprankstipranks
Trending News
More News >
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
US Market

Sumitomo Dainippon Pharma Co (DNPUF) Stock Forecast & Price Target

Compare
10 Followers
See the Price Targets and Ratings of:

DNPUF Financial Forecast

DNPUF Earnings Forecast

Next quarter’s earnings estimate for DNPUF is -$0.10 with a range of -$0.10 to -$0.10. The previous quarter’s EPS was $0.14. DNPUF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year DNPUF has Performed in-line its overall industry.
Next quarter’s earnings estimate for DNPUF is -$0.10 with a range of -$0.10 to -$0.10. The previous quarter’s EPS was $0.14. DNPUF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year DNPUF has Performed in-line its overall industry.

DNPUF Sales Forecast

Next quarter’s sales forecast for DNPUF is $637.82M with a range of $558.48M to $717.15M. The previous quarter’s sales results were $772.96M. DNPUF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year DNPUF has Performed in-line its overall industry.
Next quarter’s sales forecast for DNPUF is $637.82M with a range of $558.48M to $717.15M. The previous quarter’s sales results were $772.96M. DNPUF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year DNPUF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$16.94
Buy
47.28%
Upside
Reiterated
12/15/25
Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
J.P. Morgan Analyst forecast on DNPUF
J.P. Morgan
J.P. Morgan
$10.04$11.79
Buy
2.55%
Upside
Reiterated
09/05/25
J.P. Morgan Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Citi
$6.27$7.9
Sell
-31.27%
Downside
Reiterated
08/22/25
Citi Sticks to Its Sell Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Morgan Stanley Analyst forecast on DNPUF
Morgan Stanley
Morgan Stanley
$3.45$8.47
Hold
-26.36%
Downside
Upgraded
08/22/25
Sumitomo Pharma upgraded to Equal Weight from Underweight at Morgan StanleySumitomo Pharma upgraded to Equal Weight from Underweight at Morgan Stanley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$16.94
Buy
47.28%
Upside
Reiterated
12/15/25
Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
J.P. Morgan Analyst forecast on DNPUF
J.P. Morgan
J.P. Morgan
$10.04$11.79
Buy
2.55%
Upside
Reiterated
09/05/25
J.P. Morgan Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Citi
$6.27$7.9
Sell
-31.27%
Downside
Reiterated
08/22/25
Citi Sticks to Its Sell Rating for Sumitomo Dainippon Pharma Co (DNPUF)
Morgan Stanley Analyst forecast on DNPUF
Morgan Stanley
Morgan Stanley
$3.45$8.47
Hold
-26.36%
Downside
Upgraded
08/22/25
Sumitomo Pharma upgraded to Equal Weight from Underweight at Morgan StanleySumitomo Pharma upgraded to Equal Weight from Underweight at Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sumitomo Dainippon Pharma Co

3 Months
xxx
Success Rate
6/7 ratings generated profit
86%
Average Return
+45.81%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 85.71% of your transactions generating a profit, with an average return of +45.81% per trade.
1 Year
Success Rate
6/7 ratings generated profit
86%
Average Return
+109.83%
reiterated a buy rating 3 months ago
Copying Stephen Barker's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +109.83% per trade.
2 Years
xxx
Success Rate
6/7 ratings generated profit
86%
Average Return
+113.96%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +113.96% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DNPUF Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
17
20
28
32
34
Buy
0
0
0
0
0
Hold
10
7
17
23
26
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
27
45
55
60
In the current month, DNPUF has received 34 Buy Ratings, 26 Hold Ratings, and 0 Sell Ratings. DNPUF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

DNPUF Stock Forecast FAQ

What is DNPUF’s average 12-month price target, according to analysts?
Currently, no data Available
What is DNPUF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DNPUF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is DNPUF a Buy, Sell or Hold?
      Sumitomo Dainippon Pharma Co Ltd has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Sumitomo Dainippon Pharma Co Ltd’s price target?
        Currently, no data Available
        What do analysts say about Sumitomo Dainippon Pharma Co Ltd?
        Sumitomo Dainippon Pharma Co Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of DNPUF?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.